PharmacoEconomics

Pharmacoeconomics and Health Policy: Current Applications and Prospects for the Future
pp. 425-432(8)
Authors: Greenberg P.E.; Arcelus A.; Birnbaum H.G.; Cremieux P-Y.; LeLorier J.; Ouellette P.; Slavin M.B.

Measuring the Effects of Medication Use on Health-Related Quality of Life in Patients with Rheumatoid Arthritis: A Review
pp. 433-448(16)
Authors: Nichol M.B.; Harada A.S.M.

Real World Designs in Economic Evaluation: Bridging the Gap Between Clinical Research and Policy-Making
pp. 449-458(10)
Authors: Baltussen R.; Leidl R.; Ament A.

Cost Effectiveness, Quality-Adjusted Life-Years and Supportive Care: Recombinant Human Erythropoietin as a Treatment of Cancer-Associated Anaemia
pp. 459-472(14)
Authors: Cremieux P-Y.; Finkelstein S.N.; Berndt E.R.; Crawford J.; Slavin M.B.

Linking Health-Related Quality-of-Life Indicators to Large National Data Sets
pp. 473-482(10)
Authors: Rizzo J.A.; Sindelar J.L.

Cost Effectiveness of Omeprazole and Ranitidine in Intermittent Treatment of Symptomatic Gastro-Oesophageal Reflux Disease
pp. 483-497(15)
Authors: Weir D.G.; Stålhammar N-O.; Fulton C.; Carlsson J.; Gillon K.; Peacock R.; Bardhan K.D.; Mullerlissner S.; Bigard M.; Porro G.B.; Ponce J.; Hosie J.; Scott M.

Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year
pp. 499-520(22)
Authors: Torrance G.; Walker V.; Grossman R.; Mukherjee J.; Vaughan D.; La Forge J.; Lampron N.

Cost Effectiveness of Fluticasone Propionate and Flunisolide in the Treatment of Corticosteroid-Naive Patients with Moderate Asthma
pp. 525-531(7)
Authors: Volmer T.; Kielhorn A.; Weber H.H.; Wiessmann K.J.

Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin for Acute Coronary Syndromes: A Canadian Hospital Perspective
pp. 533-542(10)
Authors: Balen R.M.; Marra C.A.; Zed P.J.; Cohen M.; Frighetto L.

Cost Effectiveness of Amphotericin B plus G-CSF Compared with Amphotericin B Monotherapy: Treatment of Presumed Deep-Seated Fungal Infection in Neutropenic Patients in the UK
pp. 543-550(8)
Authors: Flynn T.N.; Kelsey S.M.; Hazel D.L.; Guest J.F.

Cost Effectiveness of Ciprofloxacin plus Metronidazole versus Imipenem-Cilastatin in the Treatment of Intra-Abdominal Infections
pp. 551-561(11)
Authors: Walters D.J.; Solomkin J.S.; Paladino J.A.

Economic Impact of Providing Workplace Influenza Vaccination: A Model and Case Study Application at a Brazilian Pharma-Chemical Company
pp. 563-576(14)
Authors: Burckel E.; Ashraf T.; Galvão de Sousa Filho J.P.; Forleo Neto E.; Guarino H.; Yauti C.; de Barros Barreto F.; Champion L.

Cost-Effectiveness Analysis of Antiplatelet Therapy in the Prevention of Recurrent Stroke in the UK: Aspirin, Dipyridamole and Aspirin-Dipyridamole
pp. 577-593(17)
Authors: Chambers M.; Hutton J.; Gladman J.